15 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →
| FY | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| 2025 | $44M | $12M | 77.1% | 11.2% | $2M | $22M | $12M |
| 2024 | $33M | -$33M | 75.2% | 11.8% | $2M | — | $10M |
| 2023 | $20M | -$26M | 70.4% | -2.6% | -$5M | — | $2M |
| 2022 | $17M | -$10M | 74.1% | -53.5% | — | — | $1M |
| 2021 | $13M | -$27M | 61.7% | -108.7% | -$7M | $26M | $619000 |
| 2020 | $4M | -$31M | 71.4% | -621.1% | -$13M | $17M | $2M |
| 2019 | $2M | -$10M | 32.0% | -575.3% | -$6M | — | $2M |
| 2018 | $2M | -$12M | 62.5% | -388.1% | -$4M | — | $364549 |
| 2017 | $738527 | -$6M | 67.2% | -517.8% | -$2M | — | $730184 |
| 2016 | $1M | -$6M | 58.9% | -241.0% | -$3M | $5M | $133571 |
| 2015 | $965501 | -$5M | 70.5% | -459.6% | — | — | $152930 |
| 2014 | $847367 | -$6M | 74.0% | -703.8% | -$7M | — | $4M |
| 2013 | $800029 | -$11M | 76.3% | -747.0% | — | — | $182315 |
| 2012 | $769217 | -$6M | 71.4% | -788.1% | -$4M | $5M | $70325 |
| 2011 | $802572 | -$10M | 67.4% | -1097.6% | -$9M | — | $4M |
| Quarter | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| Mar '26 | $10M | -$1M | 77.3% | -11.7% | $374000 | $21M | $11M |
| Dec '25 | $13M | $6M | 74.1% | 4.7% | $3M | $22M | $12M |
| Sep '25 | $11M | $10M | 77.6% | 8.0% | $556000 | $23M | $10M |
| Jun '25 | $10M | $551000 | 78.1% | 14.3% | -$166000 | — | $8M |
| Mar '25 | $9M | -$6M | 79.0% | 6.4% | -$2M | — | $9M |
| Dec '24 | $10M | -$14M | 77.9% | 9.2% | $505000 | — | $10M |
| Sep '24 | $9M | -$21M | 75.5% | 15.8% | $1M | — | $3M |
| Jun '24 | $7M | $6M | 73.2% | 23.0% | -$760000 | — | $2M |
| Mar '24 | $6M | -$5M | 72.6% | -18.1% | $986000 | — | $3M |
| Dec '23 | $7M | $18M | 69.1% | 14.9% | -$1M | — | $2M |
| Sep '23 | $5M | -$24M | 71.5% | -10.7% | -$2M | — | $1M |
| Jun '23 | $5M | -$7M | 74.3% | 19.9% | -$995000 | — | $332000 |
| Mar '23 | $4M | -$13M | 66.6% | -52.4% | -$389000 | — | $106000 |
| Dec '22 | $6M | -$6M | 78.4% | -26.6% | — | — | $1M |
| Sep '22 | $4M | -$1M | 72.2% | -59.6% | -$8M | — | $1M |
| Jun '22 | $4M | $2M | 71.8% | -78.5% | -$2M | $25M | $1M |
| Mar '22 | $3M | -$5M | 72.2% | -61.2% | -$3M | $25M | $313000 |
| Dec '21 | $4M | -$9M | 68.8% | -55.6% | $9000 | $26M | $619000 |
| Sep '21 | $4M | -$4M | 58.3% | -89.5% | -$1M | $24M | $327000 |
| Jun '21 | $3M | -$9M | 64.0% | -139.1% | -$2M | $21M | $264000 |
How the market has priced SNWV against its own fundamentals since 2025-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.
Over the past 5 years, SANUWAVE Health, Inc.'s revenue has grown 61.1% per year. These are computed facts, not advice.
As of FY2025, SANUWAVE Health, Inc. reported $22M of total debt against $12M of cash.
In FY2025, gross margin was 77.1%, operating margin 11.2%, and net margin 26.8%.
As of Jun '26, SANUWAVE Health, Inc. traded at a price-to-earnings ratio of about 5.6× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S have moved with the share price. These are computed facts, not advice.
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.